Stocks

Pacira BioSciences PCRX

Health care sectorNasdaq

What to see in Pacira BioSciences now

Is Wall Street adding or cutting?+11

253 13F filers hold it · +11 against the quarter before · shares held +0.9%

Holdings of 06/30
Who bought more than 5%?5.2%

State Street holds 5.2%

Filed 08/07
What comes next?10/13 (Tue)

10/13 estimated earnings

Due 10/13

Company

Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Headquarters
Brisbane, California
Fiscal year end
12/31
Next earnings
10/13, estimated
  • 253 13F filers hold it · +11 against the quarter before · shares held +0.9%Holdings of 06/30
  • State Street holds 5.2%Filed 08/07

Funds

13F filers: 253 · +11 since the quarter before · 06/30 holdings

Famous funds that held Pacira BioSciences in their latest 13F report.

FundValueSince the quarter before
Mirae Asset Global ETFS HoldingsPacira BioSciences PCRX · 06/30 holdings$463.4KNo quarter before
Mirae Asset Global InvestmentsPacira BioSciences PCRX · 06/30 holdings$44.7KTrimmed −16.7%
All tracked funds

5% stakes

Holder
State Street08/075.2%2,059,977 shFirst report
Vanguard Portfolio Management05/016.38%2,585,964 shFirst report
Vanguard Capital Management05/015.15%2,088,291 shFirst report
Dimensional Fund Advisors04/095.1%2,060,597 shFirst report
Doma Perpetual Capital Management03/127.3%2,936,794 sh+0.5pp
Doma Perpetual Capital Management01/026.83%2,936,794 sh+0.0pp
Renaissance Technologies25/11/134.98%2,138,201 sh−0.4pp
Doma Perpetual Capital Management25/11/106.83%2,936,794 sh+1.1pp
Renaissance Technologies25/08/135.34%2,395,601 shFirst report
Doma Perpetual Capital Management25/08/085.7%2,698,618 shFirst report
Pacer Advisors25/05/021.28%601,668 sh−5.7pp
Pacer Advisors25/05/026.93%3,262,837 shFirst report
Millennium Management25/04/210.7%345,625 sh−4.4pp
Millennium Management25/01/155.1%2,338,369 shFirst report
All 5% stake reports on Pacira BioSciences

26-week trading